Newer drugs fall short of hopes and cost too much, say experts who pledge to improve care in poorer countries Progress against cancer is stalling, with the latest targeted cancer drugs failing to live up to expectations and priced so high that treatment is becoming unaffordable even in rich countries, according to experts at a meeting of nearly 100 eminent cancer specialists from around the world. At the two-day meeting in Lugano, Switzerland, the doctors agreed a 10-point declaration, to be pub...
Newer drugs fall short of hopes and cost too much, say experts who pledge to improve care in poorer countries Progress against cancer is stalling, with the latest targeted cancer drugs failing to live up to expectations and priced so high that treatment is becoming unaffordable even in rich countries, according to experts at a meeting of nearly 100 eminent cancer specialists from around the world. At the two-day meeting in Lugano, Switzerland, the doctors agreed a 10-point declaration, to be pub...
Share this Article
Recommended